1. Home
  2. RUSHB vs TGTX Comparison

RUSHB vs TGTX Comparison

Compare RUSHB & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rush Enterprises Inc. Class B

RUSHB

Rush Enterprises Inc. Class B

HOLD

Current Price

$64.12

Market Cap

4.9B

ML Signal

HOLD

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$28.88

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUSHB
TGTX
Founded
1965
1993
Country
United States
United States
Employees
7388
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.9B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
RUSHB
TGTX
Price
$64.12
$28.88
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$50.67
AVG Volume (30 Days)
41.0K
1.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.13%
N/A
EPS Growth
N/A
1746.67
EPS
N/A
2.77
Revenue
N/A
$2,785,000.00
Revenue This Year
N/A
$90.97
Revenue Next Year
$1.77
$45.74
P/E Ratio
$16.53
$10.63
Revenue Growth
N/A
N/A
52 Week Low
$47.71
$25.37
52 Week High
$67.27
$46.48

Technical Indicators

Market Signals
Indicator
RUSHB
TGTX
Relative Strength Index (RSI) 51.69 44.72
Support Level $62.82 $27.25
Resistance Level $67.19 $33.05
Average True Range (ATR) 2.07 1.13
MACD -0.32 0.04
Stochastic Oscillator 30.37 27.69

Price Performance

Historical Comparison
RUSHB
TGTX

About RUSHB Rush Enterprises Inc. Class B

Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.

Share on Social Networks: